Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)

Tetrathiomolybdate (choline salt; ATN-224), a specific, high-affinity copper binder, is currently being evaluated in several phase II cancer trials. ATN-224 inhibits CuZn superoxide dismutase 1 (SOD1) leading to antiangiogenic and antitumour effects. The pharmacodynamics of tetrathiomolybdate has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Doñate, F, Juarez, J C, Burnett, M E, Manuia, M M, Guan, X, Shaw, D E, Smith, E L P, Timucin, C, Braunstein, M J, Batuman, O A, Mazar, A P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259182/
https://www.ncbi.nlm.nih.gov/pubmed/18253124
http://dx.doi.org/10.1038/sj.bjc.6604226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259182/
https://www.ncbi.nlm.nih.gov/pubmed/18253124
http://dx.doi.org/10.1038/sj.bjc.6604226

Ejemplares similares